

Learn how Symproic (Naldemedine) works to treat opioid-induced constipation. Plain English explanation of its mechanism of action.
Symproic (Naldemedine) treats opioid-induced constipation (OIC) by blocking opioid receptors in your gut — without blocking the opioid receptors in your brain that control pain. This means your bowels can work normally again while your pain medication keeps doing its job.
If you want the full picture, keep reading. We'll explain what opioids do to your digestive system, how Symproic reverses that, and why it doesn't affect your pain relief.
To understand how Symproic works, you need to understand why opioids cause constipation in the first place.
Your body has opioid receptors in many places — your brain, spinal cord, and throughout your gastrointestinal (GI) tract. When you take an opioid pain medication like Oxycodone, Hydrocodone, Morphine, or Fentanyl, the drug binds to these receptors.
In your brain, opioids block pain signals. That's the intended effect.
In your gut, opioids cause several problems:
The result? Constipation that can be severe, uncomfortable, and resistant to regular laxatives. This is opioid-induced constipation, and it affects up to 80% of people taking opioids long-term.
Symproic is classified as a peripherally-acting mu-opioid receptor antagonist, or PAMORA. Let's break that down:
When you take Symproic, the Naldemedine molecules travel to your GI tract and compete with your opioid medication for the mu-opioid receptors there. By blocking these receptors, Symproic reverses the constipation effects:
The end result is that your bowels start moving normally again.
This is the key question — and the reason PAMORAs like Symproic are so useful.
Your brain is protected by the blood-brain barrier (BBB), a tightly controlled boundary that prevents many substances in your blood from entering your brain. Symproic is specifically designed so that it does not significantly cross the blood-brain barrier.
This means:
Your opioid pain medication still binds to the brain receptors and provides pain relief, while Symproic blocks the gut receptors and relieves constipation. Each drug works where it's needed without interfering with the other.
Symproic isn't the only PAMORA on the market. Here's how it compares:
Movantik is a modified form of Naloxone designed to stay outside the blood-brain barrier. It works the same way as Symproic — blocking gut opioid receptors — but must be taken on an empty stomach (at least one hour before or two hours after food). Symproic can be taken with or without food, which many patients find more convenient.
Relistor is available as a subcutaneous injection or an oral tablet. The injection form works quickly (often within 30 to 60 minutes) but requires needle administration. The oral form (450 mg) is much larger than Symproic's tiny 0.2 mg tablet.
All three PAMORAs work on the same principle — block gut opioid receptors without crossing the blood-brain barrier. The differences come down to convenience, dosing, and how your body handles the drug. Symproic's once-daily dosing and flexibility with food make it a practical choice for many patients.
For a broader look at your options, see Alternatives to Symproic.
Here's a simplified timeline of what happens when you take your daily Symproic tablet:
Many patients notice improvement within the first few days of starting Symproic. In clinical trials, patients taking Symproic had significantly more bowel movements per week compared to placebo, with effects seen as early as the first week.
However, it may take a few days for your body to adjust. Some patients experience diarrhea or abdominal cramping initially as their gut function returns to normal. These effects usually settle down quickly. Read more in Symproic Side Effects: What to Expect.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.